HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi An Selected Research

morroniside

1/2018Morroniside on anti-inflammation activities in rats following acute myocardial infarction.
6/2009Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity.
9/2008[Morroniside inhibits H2O2-induced apoptosis in cultured nerve cells].
2/2008Morroniside prevents peroxide-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi An Research Topics

Disease

21Neoplasms (Cancer)
01/2022 - 08/2006
8Squamous Cell Carcinoma of Head and Neck
01/2022 - 08/2006
6Myocardial Infarction
01/2022 - 01/2018
6Cardiovascular Diseases (Cardiovascular Disease)
10/2020 - 06/2015
5Inflammation (Inflammations)
01/2022 - 05/2014
4Prostatic Neoplasms (Prostate Cancer)
01/2022 - 11/2020
3Atherosclerosis
01/2021 - 05/2015
3Myocardial Ischemia (Ischemic Heart Diseases)
11/2020 - 01/2017
3Infarction (Infarctions)
08/2020 - 01/2017
3Cardiotoxicity
01/2020 - 12/2016
3Heart Failure
01/2020 - 12/2011
3Neuroblastoma
06/2009 - 02/2008
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2012
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 01/2020
2Neoplasm Metastasis (Metastasis)
01/2022 - 01/2020
2Brain Neoplasms (Brain Tumor)
01/2022 - 10/2017
2Infections
10/2021 - 10/2012
2Fibrosis (Cirrhosis)
01/2021 - 11/2017
2Melanoma (Melanoma, Malignant)
12/2020 - 10/2017
2Myocardial Reperfusion Injury
08/2020 - 01/2017
2Body Weight (Weight, Body)
08/2020 - 11/2017
2Necrosis
01/2020 - 11/2017
2Head and Neck Neoplasms (Head and Neck Cancer)
11/2019 - 01/2012
2Coronary Disease (Coronary Heart Disease)
08/2019 - 06/2015
2Hypertension (High Blood Pressure)
08/2018 - 06/2015
2Endometrial Neoplasms (Endometrial Cancer)
03/2018 - 04/2015
2Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2018 - 08/2017
2Ischemia
12/2017 - 11/2017
2Hyperplasia
05/2015 - 01/2006
2Bacterial Infections (Bacterial Infection)
01/2015 - 01/2014
2Carcinoma (Carcinomatosis)
11/2013 - 01/2011
1Cystitis
01/2022
1Adenocarcinoma of Lung
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1Urinary Retention
01/2022
1Asthma (Bronchial Asthma)
01/2022
1Heart Diseases (Heart Disease)
01/2022
1Fever (Fevers)
10/2021
1COVID-19
10/2021
1Glaucoma
01/2021
1Astrocytoma (Pilocytic Astrocytoma)
01/2021
1Dehydration (Water Stress)
01/2021
1Hepatic Encephalopathy
01/2021
1Myocarditis (Carditis)
01/2021
1Second Primary Neoplasms (Neoplasms, Second)
12/2020

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2019
6MicroRNAs (MicroRNA)IBA
01/2022 - 08/2018
6Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2006
4morronisideIBA
01/2018 - 02/2008
3Circular RNAIBA
01/2022 - 01/2020
3salicylhydroxamic acid (SHAM)IBA
01/2018 - 11/2017
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 08/2006
2CaspasesIBA
01/2022 - 06/2012
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
2Untranslated RNA (Noncoding RNA)IBA
01/2022 - 01/2020
2AntigensIBA
01/2022 - 10/2017
2Inhibitor of Apoptosis ProteinsIBA
01/2021 - 11/2019
2Pharmaceutical PreparationsIBA
01/2021 - 03/2013
2CytokinesIBA
11/2020 - 11/2017
2baicaleinIBA
01/2020 - 01/2020
2Interleukin-10 (Interleukin 10)IBA
11/2019 - 11/2017
2Interleukin-6 (Interleukin 6)IBA
11/2019 - 11/2017
2LigandsIBA
11/2019 - 05/2014
2LipidsIBA
11/2017 - 11/2017
2AlginatesIBA
01/2017 - 12/2016
2OligosaccharidesIBA
01/2017 - 12/2016
2Anti-Bacterial Agents (Antibiotics)IBA
01/2015 - 01/2014
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2015 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
05/2014 - 08/2006
2Imatinib Mesylate (Gleevec)FDA Link
01/2011 - 08/2006
1Long Noncoding RNAIBA
01/2022
1Coloring Agents (Dyes)IBA
01/2022
1adavosertibIBA
01/2022
1Anaplastic Lymphoma KinaseIBA
01/2022
1B7-H1 AntigenIBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1hepsinIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Nucleic AcidsIBA
10/2021
1oxidized low density lipoproteinIBA
01/2021
1birinapantIBA
01/2021
1Abscisic AcidIBA
01/2021
1Baculoviral IAP Repeat-Containing 3 ProteinIBA
01/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2021
1MethazolamideFDA LinkGeneric
01/2021
1QuercetinIBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Carbonic Anhydrase IIBA
01/2021
1Therapeutic UsesIBA
01/2021
1STAT1 Transcription FactorIBA
01/2021
1GATA Transcription FactorsIBA
01/2021
1Immune Checkpoint InhibitorsIBA
12/2020

Therapy/Procedure

11Radiotherapy
01/2022 - 11/2013
11Therapeutics
01/2021 - 12/2011
3Prostatectomy (Retropubic Prostatectomy)
01/2022 - 11/2020
2Percutaneous Coronary Intervention
10/2020 - 08/2019
2Brachytherapy
10/2018 - 03/2018
2Stents
05/2015 - 01/2006
1Blood Transfusion (Blood Transfusions)
01/2022